Dr Frankie Rawson of the School of Pharmacy has been awarded almost £1m from the Engineering and Physical Sciences Research Council (EPSRC) to develop his research into bioelectronic technologies, which are set to transform healthcare.
Dr Rawson is investigating how bioelectronic devices will use electrochemical-based wireless technology to avoid invasive surgery, and also be applied to treat diseases such as cancer via the control of the body’s electrical signals.
He was awarded £950,798 to further his research by the EPSRC. Its Chief Executive Professor Philip Nelson said: “EPSRC’s Healthcare Technologies Challenge Awards are designed to equip the next generation of research leaders with the tools they need to tackle current and emerging health challenges facing society.”
Dr Rawson said: “We are on the brink of a new era of therapeutic intervention that relies on modulating the body’s cellular electrical signals by merging biology with electronics, termed bioelectronic therapeutics or electroceutics. With strong support from the University of Nottingham I am leading an international multidisciplinary team, consisting of engineers, physicists, biologists, chemists and clinicians, to develop a new class of technology that stands to make an impact on human health and well-being.”
Nottingham leaders united to take a stand against hate crime at a special event on Monday […]
The Survival Mandarin course is open to all staff and students at the University of Nottingham and is […]